WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the third quarter ended September 30, 2024 and provided key business updates.
Read more at globenewswire.comWindtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
WINDTREE THERAPEUTICS INC
NASDAQ:WINT (2/11/2025, 8:00:01 PM)
After market: 0.22 +0.06 (+37.5%)0.16
+0.02 (+13.15%)
WINT Latest News and Analysis
18 days ago - ChartmillFriday's after hours session: top gainers and losersWondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
